Web Results

en.wikipedia.org/wiki/Tenecteplase

Tenecteplase is an enzyme used as a thrombolytic drug. Tenecteplase is a tissue plasminogen activator (tPA) produced by recombinant DNA technology using ...

www.tnkase.com

Learn more about single-bolus TNKase® (tenecteplase) acute myocardial infarction treatment and the 5-second TNKase® dosing and administration. Indication ...

reference.medscape.com/drug/tnk-tpa-tnkase-tenecteplase-342291

Medscape - Indication-specific dosing for TNK tPA, TNKase (tenecteplase), frequency-based adverse effects, comprehensive interactions, contraindications,  ...

www.gene.com/download/pdf/tnkase_prescribing.pdf

administration after reconstitution with Sterile Water for Injection (SWFI),. USP. Each vial of TNKase nominally contains 52.5 mg Tenecteplase,. 0.55 g L- arginine, ...

www.drugs.com/mtm/tenecteplase.html

Physician reviewed tenecteplase patient information - includes tenecteplase description, dosage and directions.

www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0012329

Tenecteplase is used to dissolve blood clots that have formed in the blood vessels of the heart and seriously lessen the flow of blood in the heart. This medicine ...

lifeinthefastlane.com/ccc/tenecteplase-tnk-tpa

CLASS. thrombolytic. MECHANISM OF ACTION. selectively binds to fibrin and converts plasminogen -> plasmin -> degradation of fibrin matrix.

www.drugbank.ca/drugs/DB00031

Jun 13, 2005 ... Tenecteplase is a fibrin-specific tissue-plasminogen activator. It binds to fibrin rich clots and cleaves the Arg/Val bond in plasminogen to form ...

www.clevelandclinicmeded.com/medicalpubs/pharmacy/JanFeb2001/tenecteplase.htm

Tenecteplase has an initial half-life of 20 to 24 minutes with a terminal half-life of 90 to 130 minutes with a mean plasma clearance ranging from 99 to 119 ...